Markov model in the evaluation of breast cancer screening
program in the Czech Republic

D 2007

Markov model in the evaluation of breast cancer screening program in the Czech Republic

BUREŠOVÁ, Lucie a Eva GELNAROVÁ

Základní údaje

Originální název

Markov model in the evaluation of breast cancer screening program in the Czech Republic

Název česky

Markovský model v hodnocení screeningového programu karcinomu prsu v České republice

Autoři

BUREŠOVÁ, Lucie a Eva GELNAROVÁ

Vydání

Brno, Czech Republic, TIES 2007, s. 42-42, 2007

Nakladatel

TIES

Další údaje

Jazyk

angličtina

Typ výsledku

Stať ve sborníku

Obor

30200 3.2 Clinical medicine

Stát vydavatele

Česká republika

Utajení

není předmětem státního či obchodního tajemství

Organizační jednotka

Lékařská fakulta

ISBN

978-80-210-4333-6

Klíčová slova anglicky

breast cancer; screening; Markov model; mean sojourn time; sensitivity; interval cancers

Štítky

breast cancer, interval cancers, Markov Model, mean sojourn time, screening, sensitivity

Změněno: 27. 6. 2008 14:13, RNDr. Lucie Burešová

Anotace

ORIG CZ

V originále

Breast cancer is the most common women cancer and the second most common cause of death from cancer in industrially developed countries. It has been shown with randomised trials that screening by mammography reduces by 30% mortality from breast cancer for women aged 50 years or more. In the Czech Republic, national-wide mammographic screening programme for breast cancer has started in September 2002. Generally, it is desirable to estimate the effect of screening such as the sensitivity of screening test and the average length of the preclinical detectable period (mean sojourn time) to assess the ability of screening to affect subsequent mortality. Aim of this work is to make a pilot study of the affect of screening in the Czech Republic. The study is based on the data collected with MaSc - Czech national information system for data management of National Program of Screening of Breast Cancer. The three-state Markov model has been used with states: no disease - preclinical, screen detectable disease - clinical phase. Opposite to standard practices, the knowledge of interval cases (cancers diagnosed between screens) for different age groups is not required. Number of interval cases is, unfortunately, unknown in the Czech Republic, due to the existence of screening units and diagnostic centres separately.

Česky

Markovský model v hodnocení screeningového programu karcinomu prsu v České republice

Citovat

BUREŠOVÁ, Lucie a Eva GELNAROVÁ. Markov model in the evaluation of breast cancer screening program in the Czech Republic. In TIES 2007. Brno, Czech Republic: TIES, 2007, s. 42. ISBN 978-80-210-4333-6.

@inproceedings{748345,
   author = {Burešová, Lucie and Gelnarová, Eva},
   address = {Brno, Czech Republic},
   booktitle = {TIES 2007},
   keywords = {breast cancer; screening; Markov model; mean sojourn time; sensitivity; interval cancers},
   language = {eng},
   location = {Brno, Czech Republic},
   isbn = {978-80-210-4333-6},
   pages = {42-42},
   publisher = {TIES},
   title = {Markov model in the evaluation of breast cancer screening program in the Czech Republic},
   year = {2007}
}

TY  - JOUR
ID  - 748345
AU  - Burešová, Lucie - Gelnarová, Eva
PY  - 2007
TI  - Markov model in the evaluation of breast cancer screening program in the Czech Republic
PB  - TIES
CY  - Brno, Czech Republic
SN  - 9788021043336
KW  - breast cancer
KW  - screening
KW  - Markov model
KW  - mean sojourn time
KW  - sensitivity
KW  - interval cancers
N2  - Breast cancer is the most common women cancer and the second most common cause of death from cancer in industrially developed countries. It has been shown with randomised trials that screening by mammography reduces by 30% mortality from breast cancer for women aged 50 years or more. In the Czech Republic, national-wide mammographic screening programme for breast cancer has started in September 2002. Generally, it is desirable to estimate the effect of screening such as the sensitivity of screening test and the average length of the preclinical detectable period (mean sojourn time) to assess the ability of screening to affect subsequent mortality. Aim of this work is to make a pilot study of the affect of screening in the Czech Republic. The study is based on the data collected with MaSc - Czech national information system for data management of National Program of Screening of Breast Cancer. The three-state Markov model has been used with states: no disease - preclinical, screen detectable disease - clinical phase. Opposite to standard practices, the knowledge of interval cases (cancers diagnosed between screens) for different age groups is not required. Number of interval cases is, unfortunately, unknown in the Czech Republic, due to the existence of screening units and diagnostic centres separately.
ER  -

BUREŠOVÁ, Lucie a Eva GELNAROVÁ. Markov model in the evaluation of breast cancer screening program in the Czech Republic. In \textit{TIES 2007}. Brno, Czech Republic: TIES, 2007, s.~42. ISBN~978-80-210-4333-6.

Podrobný výpis o publikaci